Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 111Specimen Handling 106Cyclophosphamide 95Radiotherapy 75pembrolizumab 71Cisplatin 68Nivolumab 66fludarabine 61Carboplatin 60Biopsy 51Radiosurgery 47Paclitaxel 44Radiation 42Standard of Care 40Gemcitabine 37Doxorubicin 36Rituximab 35venetoclax 34Dexamethasone 34Surveys and Questionnaires 31fludarabine phosphate 30Radiotherapy, Intensity-Modulated 30Cytarabine 30durvalumab 27Practice Guidelines as Topic 27Blood Specimen Collection 27Ipilimumab 26Etoposide 25Drug Therapy 25Surgical Procedures, Operative 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × paricalcitol × 30 days × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed
34 enrolled 11 charts
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡